Reliance on china Diagu channel highlighted.
I see significant risk and lower ROE and ROCE from moving into manufacturing (rather then outsourcing product creation)
Would like to see significant traction in USA. Originally brought at $1.64 in personal portfolio.
Thesis is Changing (changing from Sales / R&D / Capital light business into capital intensive (Manufacturing)